#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Meningitis meningococcal Myxoid liposarcoma Prolymphocytic leukaemia Congenital hypotransferrinaemia X-linked lymphoproliferative syndrome Chorioretinitis Pleomorphic leiomyosarcoma Pustular psoriasis Pulmonary alveolar haemorrhage Interstitial lung disease Narcolepsy Acute myeloid leukaemia recurrent Osteochondrodysplasia Mantle cell lymphoma refractory Cutaneous lupus erythematosus More trials…

    Learn about Rare Diseases

    Retinoblastoma – Life with Disease Kearns-Sayre syndrome – Life with Disease Bronchiolitis obliterans syndrome – Treatment Chronic granulomatous disease Fabry’s disease – Treatment Turner’s syndrome – Diagnostics Isodicentric chromosome 15 syndrome – Life with Disease Congenital generalised lipodystrophy – Diagnostics Hereditary motor and sensory neuropathy – Diagnostics Waldenstrom’s macroglobulinaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alogliptin [11C]Az14193391 Oxycodone Hydrochloride Flortaucipir (18F) Int-787 204-NETU Bay 2927088 ALN-4324 Ralinepag IDOR-1117-2520C Tak-280 Glucose, Anhydrous Tilsotolimod Sodium BLEXIMENIB Zoledronic Acid Monohydrate Durvalumab TUB-030 AMO959 LY3848575 Ecoo1A More therapies…

    Learn about Your Condition

    Facial paresis Interstitial lung disease Anaemia of pregnancy Emphysema Toxic nodular goitre Primary hyperthyroidism Cystic fibrosis Small cell lung cancer Biliary cancer metastatic Pancreatic carcinoma Measles Thromboembolectomy Psoriasis Angiosarcoma Carotid arteriosclerosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Synexus Polska Sp. z o.o.

Synexus Polska Sp. z o.o.

Aleja Najswietszej Maryi Panny 15, Czestochowa, 42-202, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study comparing aciclovir gel and cream effectiveness in treating recurrent cold sores (herpes labialis)

    Recruiting

    3 1 1
    Investigated Drugs:
    • Aciclovir
    Poland
  • Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

    Recruiting

    3 1
    Investigated Diseases:
    • Hepatic fibrosis
    Investigated Drugs:
    • Efruxifermin
    France Germany Italy Poland Spain
  • Study on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    Investigated Drugs:
    • Calcium Lactate Gluconate
    • Colecalciferol
    • Ascorbic Acid
    Bulgaria Estonia Hungary Latvia Poland Slovakia
  • Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Austria Belgium Bulgaria Czechia Denmark Finland +11
  • Study on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Duvakitug
    Austria Bulgaria Czechia Germany Hungary Italy +4
  • Study on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Desoximetasone
    • Folic Acid
    • Methotrexate
    Czechia France Italy Poland
  • Study on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Deucravacitinib
    Bulgaria Czechia Finland France Hungary Ireland +4
  • Study on the Effectiveness and Safety of NT 201 Injections for Adults with Chronic Neuropathic Pain from Postherpetic Neuralgia or Nerve Injury

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neuralgia
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    • Paracetamol
    Bulgaria France Germany Hungary Poland Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!